FAQ/Help |
Calendar |
Search |
Today's Posts |
07-30-2008, 06:27 PM | #1 | ||
|
|||
Senior Member
|
http://www.medicalnewstoday.com/articles/116566.php
The gist of the article: Phase II trial completed: results: "appeared to slow the progression of the disease by as much as 81 per cent over a year, compared to placebo" Brains scans were done to confirm trial results. Very encouraging, also the jab-in-the-neck article I posted earlier, using Enbrel (drug already approved for rhumatoid arthritis |
||
Reply With Quote |
Reply |
|
|